GH
GH
NASDAQ · Health Care

Guardant Health Inc

$83.59
-1.37 (-1.61%)
As of Mar 24, 9:42 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.07B
Net Income
-455,465,914
Gross Margin
64.5%
Profit Margin
-42.4%
Rev Growth
+29.8%
D/E Ratio
7.18
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 64.5% 64.5% 30.9% 30.9%
Operating Margin -45.0% -40.5% 14.6% 16.7%
Profit Margin -42.4% -40.3% 11.5% 9.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.07B 828.04M 7.04B 5.99B
Gross Profit 692.60M 533.75M 2.18B 1.85B
Operating Income -483,721,665 -335,503,620 1.03B 1.00B
Net Income -455,465,914 -315,905,766 807.48M 594.42M
Gross Margin 64.5% 64.5% 30.9% 30.9%
Operating Margin -45.0% -40.5% 14.6% 16.7%
Profit Margin -42.4% -40.3% 11.5% 9.9%
Rev Growth +29.8% +29.8% -5.5% +12.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 5.13B 5.13B 6.09B 7.02B
Total Equity 713.88M 713.88M 6.61B 7.23B
D/E Ratio 7.18 7.18 0.92 0.97
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -446,412,289 -326,827,739 1.28B 1.22B
Free Cash Flow 648.32M 388.65M